Evidence of a malonyl-CoA-insensitive carnitine palmitoyltransferase I activity in red skeletal muscle

American Journal of Physiology. Endocrinology and Metabolism
Jong-Yeon KimDeborah M Muoio

Abstract

Carnitine palmitoyltransferase I (CPT I), which is expressed as two distinct isoforms in liver (alpha) and muscle (beta), catalyzes the rate-limiting step in the transport of fatty acid into the mitochondria. Malonyl-CoA, a potent inhibitor of CPT I, is considered a key regulator of fatty acid oxidation in both tissues. Still unanswered is how muscle beta-oxidation proceeds despite malonyl-CoA concentrations that exceed the IC(50) for CPT Ibeta. We evaluated malonyl-CoA-suppressible [(14)C]palmitate oxidation and CPT I activity in homogenates of red (RG) and white (WG) gastrocnemius, soleus (SOL), and extensor digitorum longus (EDL) muscles. Adding 10 microM malonyl-CoA inhibited palmitate oxidation by 29, 39, 60, and 89% in RG, SOL, EDL, and WG, respectively. Thus malonyl-CoA resistance, which correlated strongly (0.678) with absolute oxidation rates (RG > SOL > EDL > WG), was greater in red than in white muscles. Similarly, malonyl-CoA-resistant palmitate oxidation and CPT I activity were greater in mitochondria from RG compared with WG. Ribonuclease protection assays were performed to evaluate whether our data might be explained by differential expression of CPT I splice variants. We detected the presence of two CPT Ibeta sp...Continue Reading

References

Jun 1, 1986·Biochemical Medicine and Metabolic Biology·J H VeerkampA J Wagenmakers
Jul 1, 1995·European Journal of Biochemistry·G E TrumbleW W Winder
Apr 1, 1993·The American Journal of Physiology·L A MegeneyA Bonen
Dec 1, 1996·European Journal of Biochemistry·H IijimaT Yamamoto
Feb 15, 1997·European Journal of Biochemistry·J D McGarry, N F Brown
Mar 1, 1997·The American Journal of Physiology·D J DyckA Bonen
Aug 26, 1998·Biochimica Et Biophysica Acta·G S YuT Gulick
Jan 14, 1999·The American Journal of Physiology·N B RudermanL A Witters
Feb 11, 1999·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·C PiotJ F Hocquette
Mar 25, 1999·Histochemistry and Cell Biology·R S StaronG E Campos
Mar 11, 2000·American Journal of Physiology. Endocrinology and Metabolism·E C StarrittL L Spriet
Jun 14, 2000·Journal of Applied Physiology·W W WinderJ O Holloszy
Jun 17, 2000·Biochimica Et Biophysica Acta·J Kerner, C Hoppel
Jul 27, 2000·American Journal of Physiology. Endocrinology and Metabolism·D ChienN B Ruderman
Oct 29, 2000·American Journal of Physiology. Endocrinology and Metabolism·J Y KimJ A Houmard

❮ Previous
Next ❯

Citations

Sep 29, 2011·Journal of Lipid Research·Young Joo ParkYoon Kwang Lee
Sep 20, 2008·Diabetologia·J Szendroedi, M Roden
Dec 1, 2011·Histochemistry and Cell Biology·Madeleen BosmaMatthijs K C Hesselink
May 15, 2015·Diabetes·Qusai Y Al-ShareSonia M Najjar
Mar 3, 2007·The Journal of Physiology·Francis B StephensPaul L Greenhaff
Jul 4, 2012·Molecular and Cellular Endocrinology·Hayley M O'NeillGregory R Steinberg
Aug 9, 2011·Experimental and Molecular Pathology·Murilo de Oliveira LazarinClairce L Salgueiro-Pagadigorria
Nov 11, 2008·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Andrea J MorashGrant B McClelland
Mar 6, 2007·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Sandrine Skiba-CassySophie Tesseraud
Nov 17, 2004·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Grant B McClelland
Dec 21, 2005·Biochemical and Biophysical Research Communications·Woo Je LeeJoong-Yeol Park
Jul 19, 2015·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Takaoki SaneyasuHiroshi Kamisoyama
Sep 10, 2014·Biochemical and Biophysical Research Communications·Won-Mo Yang, Wan Lee
Jul 5, 2008·Annual Review of Nutrition·David Saggerson
Jun 8, 2006·Annual Review of Biochemistry·Deborah M Muoio, Christopher B Newgard
Feb 6, 2017·Scientific Reports·Sabrina MucerinoGianfranco Peluso
Apr 2, 2010·Journal of Korean Medical Science·Mei Lan CuiSung Su Yun
Nov 25, 2004·American Journal of Physiology. Endocrinology and Metabolism·Agnieszka DobrzynJames M Ntambi
Jan 14, 2005·American Journal of Physiology. Cell Physiology·Timothy R KovesRonald N Cortright
Oct 13, 2005·American Journal of Physiology. Endocrinology and Metabolism·Veronic BezaireLawrence L Spriet
Dec 29, 2005·American Journal of Physiology. Endocrinology and Metabolism·Anja BehaAndreas W Herling
Dec 21, 2006·American Journal of Physiology. Endocrinology and Metabolism·Clinton R BruceEdward W Kraegen
Jul 20, 2007·American Journal of Physiology. Endocrinology and Metabolism·Robert C NolandRonald N Cortright
Feb 7, 2008·American Journal of Physiology. Endocrinology and Metabolism·Jason R BerggrenJoseph A Houmard
Oct 21, 2011·Physiological Reviews·Stefano Schiaffino, Carlo Reggiani
Mar 23, 2013·Journal of Applied Physiology·Nicholas E KimberMark Hargreaves
Nov 21, 2002·American Journal of Physiology. Endocrinology and Metabolism·Gregory R SteinbergDavid J Dyck

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.